Marquette Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
SI
IP
YIH
EA
KPP
DC
HPC
HWAM
BP
SOADOR
Marquette Asset Management's IRMD Position: Q2 2026 in Review
Marquette Asset Management held its iRadimed (IRMD) position steady in Q2 2026 at 30 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #525.
Marquette Asset Management first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.92K in Q4 2025. 22 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Marquette Asset Management held 30 shares of iRadimed worth $2.87K as of Q2 2026.
- Marquette Asset Management left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #525 holding.
- Marquette Asset Management first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
- Marquette Asset Management's iRadimed position peaked at $2.92K in Q4 2025.
- 22 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.